Medelis
2 SlideShares 8 Followers
Personal Information
Organization / Workplace
Nashville, TN United States
Industry
Medical / Health Care / Pharmaceuticals
Website
www.medelis.com
About
Medelis is a boutique oncology CRO focused on phase I through phase III oncology trials in North America and Europe. We specialize in oncology, and our entire team has deep oncology trial experience and expertise.
Contact Details
Tags
biotech oncology cro pharma biotechnology medelis pharmaceutical clinicalresearch contractresearch clinical research clinicaltrials health medicine pre-clinical contract trial pharmaceuticals patientsafety preclinical clinical research phase ii cytel phase i clinical trials adaptive trial dan-von-hoff cancer drug development trials phase i ii clinical_trial phase_i contract_research drug_development dan_von_hoff phase1
See more
  • Presentations
  • Documents
  • Infographics
Latest Most Popular

Oncological Emergencies: Hypercalcaemia

Phil Mayor • 15 years ago

Patient Problem-Solving on the Web: How do Patients Use Web Forums to Cope with Chronic Disease? [4 1530 Aud Billman]

Gunther Eysenbach • 15 years ago

The Lost Art Of Phase I Oncology Trials

Medelis • 15 years ago

BioEntrepreneurship: The Business of Biotech

MaRS Discovery District • 16 years ago

Future trends and perspectives in modern pharmaceutical biotechnology

inemet • 16 years ago

Optimizing Preclinical Proof of Concept

MaRS Discovery District • 15 years ago

Open Data In Clinical Research

Martin Fenner • 15 years ago

Logistics and Practicalities of Phase I Clinical Research

MaRS Discovery District • 16 years ago

Clinical Trials Registry

biinoida • 15 years ago

The Cochrane Collaboration Colloquium: Global opportunities and challenges for trial registration: Update from the WHO International Clinical Trials Registry Platform

Cochrane.Collaboration • 16 years ago

Clinical Trials in India

vaatsalya • 16 years ago

Clinical Trials Strategy: The Clinical Development Plan

MaRS Discovery District • 16 years ago

Estimating the Maximum Safe Starting Dose for First-in-Human Clinical Trials

MaRS Discovery District • 16 years ago

How web 2.0 is changing medicine

Victor Castilla • 17 years ago

Patient Safety in Clinical Trials

Medelis • 15 years ago

Medicine 2.0 with the eye of a medical student blogger

Bertalan Mesko, MD • 15 years ago

Beyond the Business Plan - Managing unexpected risks in biotechnology business development

thinkBiotech • 15 years ago

Construction of Expertise in the Age of the Internet: Psychotropic Drug Knowledge in Consumer-Constructed Websites

Shannon Hughes • 15 years ago

Science and Web2.0

Ian Mulvany • 16 years ago